News Archive

DCRI faculty contributed to a recently published an updated meta-analysis that analyzed data from five clinical trials to compare four treatment options for patients with atrial fibrillation undergoing percutaneous coronary intervention.

Representatives of the DCRI and Duke Forge contributed to a paper that recommended the NIH strengthen its data sharing requirements, beginning by requiring sharing of clinical trial data.

The coronavirus outbreak has limited in-person research, highlighting the need for more flexible, participant-friendly research models that can be conducted virtually.

Former FDA Commissioners Mark McClellan, MD, PhD, director of the Duke-Margolis Center for Health Policy, and Scott Gottlieb, MD, made recommendations for how the FDA should respond to the novel co

Elements from ADAPTABLE could be implemented in future trials to make them more efficient, the paper’s authors write.

The study sought to simultaneously test a method for identifying individuals at high risk for Alzheimer’s disease while testing the efficacy of a potential treatment aimed at targets affecting cell

Experts on data, including three DCRI faculty, recently published a report on using patient-reported health data in pragmatic trials that stemmed from an NIH Collaboratory roundtable.

Patients with acute coronary syndrome undergoing PCI had a benefit 30 days after being treated with loading dose atorvastatin, but this benefit did not extend to the 12-month results.

A recently published paper details the development and design of the FDA-funded Pediatric Migraine Registry, which has enrolled around 200 patients between the ages of 4 and 17.

The DCRI’s Sunil Rao, MD, writes that to deliver high quality care, interventional cardiologists must constantly evaluate their practice and learn new techniques and skills.